| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 514499000 | Copper | 9 |
| 20090258943 | Hybrid strategies for reducing leaching of metal biocides from biodegradable substrates - Hybrid strategies generally involve treating biodegradable substrates with preservative compositions having at least two phases in which the metal biocide is distributed among at least the two phases and via equilibrium reactions moves between the two phases. Both phases are caused to contact the substrate in a manner so that the phases are in contact with each other during at least a portion of the treatment. In illustrative embodiments, the first phase is a liquid phase comprising complexed metal biocide dissolved in a liquid carrier, while the second phase comprises particles comprising the metal biocide, often precipitated and/or colloidal particles. The strategies and related compositions, processes, and treatments are hybrid in the sense that the strategies include both heterogeneous (insoluble) and homogeneous metal biocide constituents. Unlike heterogeneous strategies, hybrid strategies are less sensitive to particle size constraints and may use biocide particles with a wider range of particle sizes. Unlike homogeneous strategies, hybrid strategies are less sensitive to pH and may use a wider range of complexing agents, including mildly alkaline amines such as triethanolamine. | 10-15-2009 |
| 20100016426 | Post-impregnation treatments to improve distribution of metal biocides in an impregnated substrate - The present invention relates to post-treatment compositions and methods useful for modifying the distribution of metal biocide(s) in biodegradable substrates such as wood, other cellulosic products, starch-based products, and the like that are vulnerable to decay due to insects, fungi, microbes, and the like. The compositions include complexing agents of moderate strength that are able to facilitate mobilization and redistribution of metal biocide(s) in substrates without undue leaching. The compositions can be used, for example, to redistribute the metal biocide(s) into depleted regions of a substrate by redistribution of metal biocide from other regions of the substrate. Post-treatment compositions that include additional metal biocide can also replenish these regions with the freshly supplied, additional biocide. Thus, the depleted regions can be restored by redistribution and/or replenishment mechanisms. Service life of substrates in the field benefits by these post-treatments as a consequence. | 01-21-2010 |
| 20110294877 | TRANSITION METAL COMPLEXES OF BIS[THIOHYDRAZIDE AMIDE] COMPOUNDS - The present invention is directed to a compound comprising a bis[thiohydrazide amide] or a deprotonated form thereof, complexed to a transition metal cation, wherein the bis[thiohydrazide amide] is represented by Structural Formula (I), or a prodrug, isomer, ester, salt, hydrate, solvate, polymorph or a deprotonated form thereof. In one embodiment, the compound is represented by Structural Formula (II), or a prodrug, isomer, ester, salt, hydrate, solvate or polymorph thereof. The present invention also provides a pharmaceutical composition comprising the compound of the invention and method of use thereof. | 12-01-2011 |
| 20130289108 | Palladium-Copper Catalysts for the Homogeneous Selective Oxidation of Thiol Groups - A palladium-copper catalyst of homogeneous selective oxidation of thiols is proposed, combining a functional binuclear thiolate-bridged coordination compound of palladium (II) and a modifying thiolate complex of copper (I), having the general formula | 10-31-2013 |
| 20130324598 | TREATING MYCOBACTERIAL INFECTION WITH CU+/++ BOOSTING THERAPEUTICS - Provided herein are methods of treating a subject with a mycobacterial infection. The methods comprise administering to the subject a Cu | 12-05-2013 |
| 20150297717 | PHARMACEUTICAL FORMULATIONS - The invention provides a pharmaceutical composition comprising (a) a compound of the formula (1), wherein R | 10-22-2015 |
| 514500000 | With an additional active ingredient | 3 |
| 20110112188 | Treatment of Inflammatory Conditions - The invention relates to methods of inhibiting production and function of 3-deoxyglucosone and other alpha-dicarbonyl sugars in skin thereby treating or prevention various diseases, disorders or conditions. Additionally, the invention relates to treatment of various diseases, disorders or conditions associated with or mediated by oxidative stress since 3DG induces ROS and AGEs, which are associated with the inflammatory response caused by oxidative stress. | 05-12-2011 |
| 20130150440 | USE OF BIS [THIOHYDRAZIDE AMIDE] COMPOUNDS SUCH AS ELESCLOMOL FOR TREATING CANCERS - Improved cancer treatments with bis[thiohydrazide amide] compounds such as elesclomol, in particular for identifying patient populations that would benefit from such treatments. | 06-13-2013 |
| 20130237598 | ANTIVIRAL COMPOSITIONS - This invention provides virucidally-enhanced alcoholic compositions. The compositions include at least about 50 wt. % of a C | 09-12-2013 |
